Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Cefotetan-induced immune hemolytic anemia following prophylaxis for cesarean delivery

In English

Författare

Summary, in English

Second- and third-generation cephalosporins, notably cefotetan, are increasingly implicated in severe, sometimes fatal immunemediated hemolytic anemia. We describe a 26-year-old woman who developed severe hemolytic anemia 2 weeks after receiving a single prophylactic dose of cefotetan during cesarean delivery. The patient's DAT was weakly reactive for IgG and her serum reacted with cefotetan-coated RBCs. The antibody had a titer of 4,096 by antiglobulin testing. The patient required treatment with two units of PRBCs and experienced gradual resolution of hemolysis. Our case emphasizes the need for increased awareness of delayed onset hemolytic anemia following prophylactic use of cefotetan.

Publiceringsår

2004

Språk

Engelska

Sidor

63-66

Publikation/Tidskrift/Serie

Immunohematology

Volym

20

Issue

1

Dokumenttyp

Artikel i tidskrift

Förlag

American Red Cross

Ämne

  • Hematology

Status

Published

ISBN/ISSN/Övrigt

  • ISSN: 0894-203X